A successful launch depends on reaching the right providers fast and clearing the access hurdles that gate adoption. This collection covers launch planning, go-to-market strategy, and market access — from building the initial target universe to navigating reimbursement and value analysis. Learn how data-driven launches concentrate early effort on high-potential adopters and build the evidence that unlocks access and scale.
Market access is the set of activities that ensure a product can reach patients — securing reimbursement, demonstrating economic and clinical value, and clearing payer, formulary, or committee requirements that gate adoption.
Start by sizing the market and identifying early-adopter providers with claims and procedure data, prioritize high-potential accounts and KOLs, then align field, marketing, and medical resources around that target universe from day one.
Common causes include targeting too broadly, underestimating access and reimbursement hurdles, and failing to engage influential providers early. Data-driven prioritization and access planning directly address these gaps.
